Top Stories of 2023: Eric Montross' Cancer Fight Galvanizes the Community
To reflect on the year, Chapelboro.com is re-publishing some of the top stories that impacted and defined our community’s experience in 2023.
Stay updated with breaking news from Cancer Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To reflect on the year, Chapelboro.com is re-publishing some of the top stories that impacted and defined our community’s experience in 2023.
Drs Simeone and Fakih discuss the main objective and design of the observational BASECAMP-1 study and how it functions alongside the EVEREST-1 study, which is evaluating the autologous CAR T-cell therapy A2B530 in patients with CEA-expressing solid tumors that have lost HLA-A*02 expression.
Adam M. Brufsky, MD, PhD, FACP, discusses the significance of the FDA approval of capivasertib in combination with fulvestrant for patients with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer harboring 1 or more PIK3CA, AKT1, or PTEN alterations.
Family fun for the week of Dec. 15
An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.